Skip to main content
Caplight Logo









Teon Therapeutics

Teon Therapeutics

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://teontherapeutics.com/

Last Round

Series A

Feb 22, 2021

Est. Valuation

$63.7M

Total Funding Raised

$37.27M

Company Overview

Teon Therapeutics is a biotechnology company that develops single-target small molecules aimed at restoring antitumor immunity and inhibiting cancer cell growth.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaloncologysmall-molecule therapytumor microenvironmentimmune response modifierclinical trialscheckpoint inhibitorsdrug discoverybiotechcancer immunotherapyclinical-stagedrug developmentinvestigational new drugINDpharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Teon Therapeutics Comparables

Compare Teon Therapeutics with similar companies based on industry and business-model similarity.

Teon Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pathios Therapeutics
83%
Arcus Biosciences
78%
Kainova Therapeutics
77%

Teon Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 22, 2021
DebtApr 15, 2020
SeedJan 24, 2019

Key People

Founding team and executive leadership

Lina Yao

Founder, President And Interim CEO

Founding Team

Teon Therapeutics Investors

Notable investors and investment history

Teon Therapeutics investors
InvestorRounds
Oriental Fortune CapitalSeries A, Seed
Kaitai CapitalSeries A, Seed
Northern Light Venture CapitalSeries A, Seed
Oceanpine CapitalSeries A
Oriza VenturesSeries A
Oriza VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2021

    $30M round led by Oceanpine Capital

Teon Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Teon Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Teon Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range7
Year Founded2018
Last FundingFeb 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?